A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction

J R Coll Gen Pract. 1979 Jul;29(204):413-6.

Abstract

A randomized controlled trial is reported in which a single dose of aspirin (300 mg) was given to patients with myocardial infarction on first contact with a general practitioner. A total of 1,705 patients with confirmed infarction were studied, and survival ascertained. There was no evidence of benefit from the aspirin.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aspirin / therapeutic use*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Male
  • Myocardial Infarction / prevention & control*
  • Random Allocation
  • Recurrence

Substances

  • Aspirin